34 Recruiting Studies Using Ifosfamide
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Ifosfamide
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma
📍 Washington University School of Medicine — St Louis, Missouri
Soft Tissue Sarcoma
View Study & Checklist ➔Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
📍 University of Florida Proton Therapy Institute — Jacksonville, Florida
Rhabdomyosarcoma
View Study & Checklist ➔Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Adult T Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study of N9 Chemotherapy in Children With Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Neuroblastoma
View Study & Checklist ➔Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
📍 Washington University School of Medicine, Siteman Cancer Center — St Louis, Missouri
Diffuse Large B-cell-lymphoma
View Study & Checklist ➔Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL
📍 City of Hope Medical Center — Duarte, California
Recurrent Hodgkin Lymphoma
View Study & Checklist ➔Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Sarcoma
View Study & Checklist ➔Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
View Study & Checklist ➔A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
📍 Hospital Aleman — Ciudad Autonoma de Buenos Aires, Buenos Aires
B-Cell Non-Hodgkin Lymphoma (B-NHL)
View Study & Checklist ➔Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma
📍 MD Anderson Cancer Center — Houston, Texas
Lymphoma
View Study & Checklist ➔Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
📍 City of Hope Medical Center — Duarte, California
Diffuse Large B-Cell Lymphoma Unclassifiable
View Study & Checklist ➔Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
📍 University of Southern California — Los Angeles, California
Germ Cell Tumors
View Study & Checklist ➔Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
📍 Children's Hospital of Alabama — Birmingham, Alabama
CIC-Rearranged Sarcoma
View Study & Checklist ➔Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
📍 Roswell Park Cancer Institute — Buffalo, New York
CD20 Positive
View Study & Checklist ➔Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Metastatic Ewing Sarcoma
View Study & Checklist ➔Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
📍 Memorial Sloan Kettering Cancer Center Basking Ridge — Basking Ridge, New Jersey
Newly Diagnosed Ewing Sarcoma
View Study & Checklist ➔International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry
📍 Anne K Harris — Minneapolis, Minnesota
Pleuropulmonary Blastoma
View Study & Checklist ➔Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
📍 Children's Hospital of Alabama — Birmingham, Alabama
Germ Cell Tumor
View Study & Checklist ➔N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
High-risk Neuroblastoma
View Study & Checklist ➔International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
📍 Los Angeles County-USC Medical Center — Los Angeles, California
Squamous Cell Carcinoma of the Penis, Usual Type
View Study & Checklist ➔A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
📍 Children's Hospital of Alabama — Birmingham, Alabama
Anaplastic Kidney Wilms Tumor
View Study & Checklist ➔Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
📍 Mayo Clinic Health Systems-Mankato — Mankato, Minnesota
Clonal Cytopenia of Undetermined Significance
View Study & Checklist ➔A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Mature B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
📍 University of Alabama — Birmingham, Alabama
NK-Cell Lymphoma
View Study & Checklist ➔Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Sarcoma
View Study & Checklist ➔Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
📍 New York Medical College — Valhalla, New York
Non-Hodgkin Lymphoma
View Study & Checklist ➔NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
📍 Children's Healthcare of Atlanta — Atlanta, Georgia
Adipocytic Neoplasm
View Study & Checklist ➔A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
📍 Children's Hospital of Alabama — Birmingham, Alabama
Central Nervous System Nongerminomatous Germ Cell Tumor
View Study & Checklist ➔Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
📍 St. Joseph's Children's Hospital — Tampa, Florida
Osteosarcoma
View Study & Checklist ➔Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
📍 University of Alabama at Birmingham (Children's of Alabama) — Birmingham, Alabama
Metastatic Ewing Sarcoma
View Study & Checklist ➔Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Pleuropulmonary Blastoma
View Study & Checklist ➔A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Osteosarcoma
View Study & Checklist ➔Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
Recurrent Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔